© 1987 Oxford University Press
research-article |
DNA methylation in rat tissues by a series of homologous aliphatic nitrosamines ranging from N-nitrosodimethylamine to N-nitrosomethyldodecylamine
1Laboratory of Neuropathology, Institute of Pathology, University of Zürich CH-8091 Zürich, Switzerland
3LBI-Basic Research Program, National Cancer Institute—Frederick Cancer Research Facility Frederick, MD 21701, USA
4To whom reprint requests should be sent
Aliphatic N-nitrosomethylalkylamines exhibit a remarkable organ specificity in rats, the principal targets for tumour induction being liver, oesophagus, urinary bladder and lung. We have determined the extent of DNA methylation in these tissues following a single oral dose (0.1 mmol/kg; 6 h survival) of each of 12 homologues, ranging from N-nitrosodimethylamine (C1) to N-nitrosomethyldodecylamine (C12). Methylpurines (7-and O6-methylguanine) were determined by cation exchange HPLC with fluorescence detection. Highest levels of hepatic DNA methylation were found with N-nitrosodimethylamine (C1) and N-nitrosomethylethylamine (C2), the most potent hepatocarcinogens in this series. Concentrations of methylpurines in liver DNA decreased with increasing chain length for C1–C5. Administration of the higher homologues (C6–C12) caused levels of DNA methylation which by themselves were considered too low to account for their hepatocarcinogenicity. In rat oesophagus, DNA methylation closely paralleled carcinogenicity, the butyl and pentyl derivatives (C4, C5) being most effective. In rat lung, the extent of DNA methylation was generally lower and there was no apparent correlation with carcinogenicity. Methylation of kidney DNA also decreased with increasing chain length and was only detectable for C1–C5. In urinary bladder DNA, methylpurines were below or close to the limit of detection. It is concluded that the initiation of malignant transformation by DNA methylation alone (through hydroxylation at the methylene 
-carbon) could be operative for Cl in kidney and lung, for Cl and C2 in liver, and C3–C5 in oesophagus. For the higher homologues, the extent of DNA methylation seems insufficient to explain the complex pattern of tissue specificity, suggesting that DNA modification other than, or in addition to, methylation may be responsible.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. L. Wong, S. E. Murphy, M. Wang, and S. S. Hecht Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3 Carcinogenesis, February 1, 2003; 24(2): 291 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Ribeiro Pinto, E. Moraes, R. M. Albano, M. C. Silva, W. Godoy, T. Glisovic, and M. A. Lang Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis Carcinogenesis, November 1, 2001; 22(11): 1877 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Konishi, M. Nakamura, E. Ishida, Y. Kawada, M. Nishimine, H. Nagai, and M. Emi Specific Genomic Alterations in Rat Renal Cell Carcinomas Induced by N-Ethyl-N-hydroxyethylnitrosamine Toxicol Pathol, February 1, 2001; 29(2): 232 - 236. [Abstract] [PDF]
|
|
|
|
|
|
N. Brookman-Amissah, A. G. Mackay, and P. F. Swann Isolation and sequencing of the cDNA of a novel cytochrome P450 from rat oesophagus Carcinogenesis, January 1, 2001; 22(1): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Haorah, D. W. Miller, R. Brand, T. C. Smyrk, X. Wang, S. C. Chen, and S. S. Mirvish Diffusion of dialkylnitrosamines into the rat esophagus as a factor in esophageal carcinogenesis Carcinogenesis, May 1, 1999; 20(5): 825 - 836. [Abstract] [Full Text] [PDF]
|
|